Biomea Fusion Company

Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.
Technology: Biotechnology, Life Science, Therapeutics
Industry: Early Drug Development
Headquarters: Redwood City, California, United States
Founded Date: 2017-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 8
Total Funding: 56000000
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-01-06
Last Funding Type: Series A

Visit Website
Register and Claim Ownership